CARBIDOPA; LEVODOPA | N203312 | IMPAX LABORATORIES LLC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Impax Laboratories, LLC v. ScieGen Pharmaceuticals, Inc. 5 patentsANDA 219953Carbidopa/Levodopa | D. Del. | 2025-10-06 | Active | — |
IMPAX LABORATORIES, LLC v. QILU PHARMACEUTICAL (HAINAN) CO., LTD. et al 5 patentsANDA 220177Carbidopa/Levodopa | D.N.J. | 2025-04-25 | Active | — |
IMPAX LABORATORIES, LLC v. QILU PHARMACEUTICAL CO., LTD. et al 5 patentsANDA 220177Carbidopa/Levodopa | D.N.J. | 2025-03-19 | Terminated 2025-07-23 | — |
IMPAX LABORATORIES, LLC v. BIOCON PHARMA LTD et al 5 patentsANDA 220119Carbidopa/Levodopa | D.N.J. | 2025-03-19 | Active | — |
IMPAX LABORATORIES, INC. v. ZYDUS PHARMACEUTICALS USA, INC. et al 1 patentANDA 210911Levodopa/Carbidopa | D.N.J. | 2017-12-21 | Terminated 2020-05-19 | — |
IMPAX LABORATORIES, INC. v. ACTAVIS LABORATORIES FL, INC. et al 6 patentsANDA 208522carbidopa and levodopa | D.N.J. | 2015-09-17 | Terminated 2018-06-25 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).